Nanoparticle strategies for cancer therapeutics: Nucleic acids, polyamines, bovine serum amine oxidase and iron oxide nanoparticles (Review)

International Journal of Oncology

Volumn 46, Issue 1, 2015, Pages 5-16

  Agostinelli, Enzo ^a   Vianello, Fabio ^b,c   Magliulo, Giuseppe ^a   Thomas, Thresia ^d   Thomas, T J ^e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c PALACKÝ UNIVERSITY   (Czech Republic)

^d RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e RUTGERS UNIVERSITY   (United States)

Author keywords

Biomaterials; Bovine serum amine oxidase; DNA nanoparticles; Gene therapy; Magnetic nanoparticles; Multidrug resistance; Polyamines

Indexed keywords

FERRIC ION; FERRIC OXIDE; NANOPARTICLE; NUCLEIC ACID; OXIDOREDUCTASE; POLYAMINE; POLYAMINE OXIDASE;

ANIMAL; BOVINE; DNA PACKAGING; DRUG DELIVERY SYSTEM; DRUG EFFECTS; HUMAN; METABOLISM; NANOMEDICINE; NEOPLASMS; PHYSIOLOGY; PROCEDURES; TRENDS;

ANIMALS; CATTLE; DNA PACKAGING; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; HUMANS; NANOMEDICINE; NANOPARTICLES; NEOPLASMS; NUCLEIC ACIDS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYAMINES;

EID: 84917689710     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2706     Document Type: Article

References (126)

1. Cheng Z, Al Zaki A, Hui JZ, Muzykantov VR and Tsourkas A: Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 338: 903-910, 2012.
2. Bertrand N, Wu J, Xu X, Kamaly N and Farokhzad OC: Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev 66: 2-25, 2014.
3. Sheridan C: Proof of concept for next-generation nanoparticle drugs in humans. Nat Biotechnol 30: 471-473, 2012.
4. Li H, LaBean TH and Leong KW: Nucleic acid-based nanoengineering: novel structures for biomedical applications. Interface Focus 1: 702-724, 2011.
5. Kawabata A, Baoum A, Ohta N, Jacquez S, Seo GM, Berkland C and Tamura M: Intratracheal administration of a nanoparticlebased therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth. Cancer Res 72: 2057-2067, 2012.
6. Stahl FW and West SC: Happy Hollidays: 40th anniversary of the Holliday junction. Nat Rev Mol Cell Biol 5: 937-944, 2004.
7. Seeman NC: Nucleic acid junctions and lattices. J Theor Biol 99: 237-247, 1982.
8. Seeman NC: Nanomaterials based on DNA. Annu Rev Biochem 79: 65-87, 2010.
9. Zadegan RM and Norton ML: Structural DNA nanotechnology: from design to applications. Int J Mol Sci 13: 7149-7162, 2012.
10. Reishus D, Shaw B, Brun Y, Chelyapov N and Adleman L: Self-assembly of DNA double-double crossover complexes into high-density, doubly connected, planar structures. J Am Chem Soc 127: 17590-17591, 2005.
11. Ke Y, Liu Y, Zhang J and Yan H: A study of DNA tube formation mechanisms using 4-, 8- and 12-helix DNA nanostructures. J Am Chem Soc 128: 4414-4421, 2006.
12. Kuzuya A, Wang R, Sha R and Seeman NC: Six-helix and eighthelix DNA nanotubes assembled from half-tubes. Nano Lett 7: 1757-1763, 2007.
13. He Y, Chen Y, Liu H, Ribbe AE and Mao C: Self-assembly of hexagonal DNA two-dimensional (2D) arrays. J Am Chem Soc 127: 12202-12203, 2005.
14. He Y, Tian Y, Ribbe AE and Mao C: Highly connected twodimensional crystals of DNA six-pointstars. J Am Chem Soc 128: 15978-15979, 2006.
15. Rothemund PW: Folding DNA to create nanoscale shapes and patterns. Nature 440: 297-302, 2006.
16. Endo M, Sugita T, Rajendran A, Katsuda Y, Emura T, Hidaka K and Sugiyama H: Two dimensional DNA origami assemblies using a four-way connector. Chem Commun 47: 3213-3215, 2011.
17. Rajendran A, Endo M, Katsuda Y, Hidaka K and Sugiyama H: Programmed two-dimensional self-assembly of multiple DNA origami jigsaw pieces. ACS Nano 5: 665-671, 2010.
18. Kuzuya A, Kimura M, Numajiri K, Koshi N, Ohnishi T, Okada F and Komiyama M: Precisely programmed and robust 2D streptavidin nanoarrays by using periodical nanometer-scale wells embedded in DNA origami assembly. Chembiochem 10: 1811-1815, 2009.
19. Shen W, Zhong H, Neff D and Norton ML: NTA directed protein nanopatterning on DNA Origami nanoconstructs. J Am Chem Soc 131: 6660-6661, 2009.
20. Hung AM, Micheel CM, Bozano LD, Osterbur LW, Wallraff GM and Cha JN: Large-area spatially ordered arrays of gold nanoparticles directed by lithographically confined DNA origami. Nat Nanotechnol 5: 121-126, 2010.
21. Lund K, Manzo AJ, Dabby N, Michelotti N, Johnson-Buck A, Nangreave J, Taylor S, Pei R, Stojanovic MN, Walter NG, et al: Molecular robots guided by prescriptive landscapes. Nature 465: 206-210, 2010.
22. Gu H, Chao J, Xiao SJ and Seeman NC: A proximity-based programmable DNA nanoscale assembly line. Nature 465: 202-205, 2010.
23. Wickham SF, Endo M, Katsuda Y, Hidaka K, Bath J, Sugiyama H and Turberfield AJ: Direct observation of stepwise movement of a synthetic molecular transporter. Nat Nanotechnol 6: 166-169, 2011.
24. Endo M, Hidaka K, Kato T, Namba K and Sugiyama H: DNA prism structures constructed by folding of multiple rectangular arms. J Am Chem Soc 131: 15570-15571, 2009.
25. Douglas SM, Dietz H, Liedl T, Hogberg B, Graf F and Shih WM: Self-assembly of DNA into nanoscale three-dimensional shapes. Nature 459: 414-418, 2009.
26. Andersen ES, Dong M, Nielsen MM, Jahn K, Subramani R, Mamdouh W, Golas MM, Sander B, Stark H, Oliveira CL, Pedersen JS, Birkedal V, Besenbacher F, Gothelf KV and Kjems J: Self-assembly of a nanoscale DNA box with a controllable lid. Nature 459: 73-76, 2009.
27. Kuzuya A and Komiyama M: Design and construction of a boxshaped 3D-DNA origami. Chem Commun 28: 4182-4184, 2009.
28. Ke Y, Sharma J, Liu M, Jahn K, Liu Y and Yan H: Scaffolded DNA origami of a DNA tetrahedron molecular container. Nano Lett 9: 2445-2447, 2009.
29. Ke Y, Ong LL, Shih WM and Yin P: Three dimensional structures self-assembled from DNA bricks. Science 338: 1177-1183, 2012.
30. Erben CM, Goodman RP and Turberfield AJ: Single-molecule protein encapsulation in a rigid DNA cage. Angew Chem Int Ed Engl 45: 7414-7417, 2006.
31. Zhao Z, Jacovetty EL, Liu Y and Yan H: Encapsulation of gold nanoparticles in a DNA origami cage. Angew Chem Int Ed Engl 50: 2041-2044, 2011.
32. Anderson CJ, Bulte JW, Chen K, Chen X, Khaw BA, Shokeen M, Wooley KL and VanBrocklin HF: Design of targeted cardiovascular molecular imaging probes. J Nucl Med 51 (Suppl 1): 3-17, 2010.
33. Douglas SM, Bachelet I and Church GM: A logic-gated nanorobot for targeted transport of molecular payloads. Science 335: 831-834, 2012.
34. Bhatia D1, Chakraborty S, Mehtab S and Krishnan Y: A method to encapsulate molecular cargo within DNA icosahedra. Methods Mol Biol 991: 65-80, 2013.
35. Pegg AE: Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 234: 249-262, 1986.
36. Thomas T and Thomas TJ: Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 58: 244-258, 2001.
37. Marton LJ and Pegg AE: Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 35: 55-91, 1995.
38. Pignatti C, Tantini B, Stefanelli C and Flamigni F: Signal transduction pathways linking polyamines to apoptosis. Amino Acids 27: 359-365, 2004.
39. Seiler N and Raul F: Polyamines and apoptosis. J Cell Mol Med 9: 623-642, 2005.
40. Cohen SS: A Guide to the Polyamines. Oxford University Press, New York, Oxford, 1998.
41. Bachrach U, Wang YC and Tabib A: Polyamines: New cues in cellular signal transduction. News Physiol Sci 16: 106-109, 2001.
42. Childs AC, Mehta DJ and Gerner EW: Polyamine-dependent gene expression. Cell Mol Life Sci 60: 1394-1406, 2003.
43. Thomas T and Thomas TJ: Regulation of cyclin B1 by estradiol and polyamines in MCF-7 breast cancer cells. Cancer Res 54: 1077-1084, 1994.
44. Goldenthal MJ and Marin-Garcia J: Mitochondrial signaling pathways: a receiver/integrator organelle. Mol Cell Biochem 262: 1-16, 2004.
45. Toninello A, Salvi M and Mondovì B: Interaction of biologically active amines with mitochondria and their role in the mitochondrial- mediated pathway of apoptosis. Curr Med Chem 11: 2349-2374, 2004.
46. Thomas TJ and Bloomfield VA: Collapse of DNA caused by trivalent cations: pH and ionic specificity effects. Biopolymers 22: 1097-1106, 1983.
47. Vijayanathan V, Thomas T and Thomas TJ: DNA nanoparticles and development of DNA delivery vehicles for gene therapy. Biochemistry 41: 14085-14094, 2002.
48. Teif VB and Bohinc K: Condensed DNA: condensing the concepts. Prog Biophys Mol Biol 105: 208-222, 2011.
49. Todd BA, Parsegian VA, Shirahata A, Thomas TJ and Rau DC: Attractive forces between cation condensed DNA double helices. Biophys J 94: 4775-4782, 2008.
50. Carlstedt J, Lundberg D, Dias RS and Lindman B: Condensation and decondensation of DNA by cationic surfactant, spermine, or cationic surfactant-cyclodextrin mixtures: macroscopic phase behaviour, aggregate properties, and dissolution mechanisms. Langmuir 28: 7976-7989, 2012.
51. Saminathan M, Antony T, Shirahata A, Sigal LH, Thomas T and Thomas TJ: Ionic and structural specificity effects of natural and synthetic polyamines on the aggregation and resolubilization of single, double, and triple-starnded DNA. Biochemistry 38: 3821-3830, 1999.
52. Saraf A, Hacker MC, Sitharaman B, Grande-Allen KJ, Barry MA and Mikos AG: Synthesis and conformational evaluation of a novel gene delivery vector for human mesenchymal stem cells. Biomacromolecules 9: 818-827, 2008.
53. Nayvelt I, Thomas T and Thomas TJ: Mechanistic differences in DNA nanoparticle formation in the presence of oligolysines and poly-L-lysine. Biomacromolecules 8: 477-484, 2007.
54. Vijayanathan V, Thomas T, Shirahata A and Thomas TJ: DNA condensation by polyamines: a laser light scattering study of structural effects. Biochemistry 40: 13644-13651, 2001.
55. Thomas RM, Thomas T, Wada M, Sigal LH, Shirahata A and Thomas TJ: Facilitation of the cellular uptake of a triplex forming oligonucleotide by polyamine analogues: structure-activity relationships. Biochemistry 38: 13328-13337, 1999.
56. Seiler N: Polyamine catabolism and elimination by the vertebrate organism. In: Polyamines in the Gastrointestinal Tract. Dowling RH, Fölsch UR and Löser G (eds). Kluwer Academic Publishers, Dordrecht, pp65-85, 1992.
57. Agostinelli E, Arancia G, Dalla Vedova L, Belli F, Marra M, Salvi M and Toninello A: The biological functions of polyamine oxidation products by amine oxidases: perspectives of clinical applications. Amino Acids 27: 347-358, 2004.
58. Mondovì B, Riccio P, Agostinelli E and Marcozzi G: Oxidation of diamines and polyamines. In: The Physiology of Polyamines. Bachrach U and Heimer YM (eds). Vol. 1. CRC Press, Boca Raton, FL, pp177-201, 1989.
59. Binda C, Mattevi A and Edmondson DL: Structure-function relationships in flavoenzyme-dependent amine oxidations. J Biol Chem 277: 23973-23976, 2002.
60. Janes SM, Mu D, Wemmer D, Smith AJ, Kaur S, Maltby D, Burlingame AL and Klinman JP: A new redox cofactor in eukaryotic enzymes: 6-hydroxydopa at the active site of bovine serum amine oxidase. Science 248: 981-987, 1990.
61. Edmondson DL, Binda C and Mattevi A: Structural insights into the mechanism of amine oxidation by monoamine oxidase A and B. Arch Biochem Biophis 464: 269-276, 2007.
62. Edmondson DL, Binda C, Wang J, Upadhyay AK and Mattevi A: Molecular and mechanistic properties of the membranebound mitochondrial monoamine oxidases. Biochemistry 48: 4220-4230, 2009.
63. Agostinelli E, Tempera G, Molinari A, Salvi M, Battaglia V, Toninello A and Arancia G: The phisiological role of biogenic amines redox reactions in mitochondria. New perspective in cancer therapy. Amino Acids 33: 175-187, 2007.
64. Agostinelli E, Tempera G, Tandurella E, Pintus F, Spanò D, Medda R and Floris G: The role of copper amine oxidases in the metabolism of polyamine and their therapeutic implications. In: Biological Aspects of Biogenic Amines, Polyamines and Conjugates. Dandrifosse G (ed). ISBN: 978-81-7895-249-9. Transworld Research Network, 2009.
65. Floris G and Mondovì B: Copper Amine Oxidases. CRC Press, Boca Ranton, FL, 2009.
66. Wang Y, Devereux W, Woster PM, Stewart TM, Hacker A and Casero RA Jr : Cloning and characterization of human polyamine oxidase that is inducible by polyamine analogue exposure. Cancer Res 61: 5370-5373, 2001.
67. Vujcic S, Diegelman P, Bacchi CJ, Kramer DL and Porter CW: Identification and characterization of a novel flavin containing spermine oxidase of mammalian cell origin. Biochem J 367: 665-675, 2002.
68. Casero RA Jr and Marton LJ: Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov 6: 373-390, 2007.
69. Babbar N and Casero RA Jr: Tumor necrosis factor α increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for inflammation induced carcinogenesis. Cancer Res 66: 11125-11130, 2006.
70. Casero RA Jr and Pegg A: Polyamine catabolism and disease. Biochem J 421: 323-338, 2009.
71. Seiler N: Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors. Curr Drug Targets 4: 537-564, 2003.
72. Seiler N: Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivatives. Curr Drug Targets 4: 565-585, 2003.
73. Averill-Bates DA, Cherif A, Agostinelli E, Tanel A and Fortier G: Anti-tumoral effect of native and immobilized bovine serum amine oxidase in a mouse melanoma model. Biochem Pharmacol 69: 1693-1704, 2005.
74. Agostinelli E, Belli F, Molinari A, Condello M, Palmigiani P, Vedova LD, Marra M, Seiler N and Arancia G: Toxicity of enzymatic oxidation products of spermine to human melanoma cells (M14): sensitisation by heat and MDL 72527. Biochim Biophys Acta 1763: 1040-1050, 2006.
75. Agostinelli E, Dalla Vedova L, Belli F, Condello M, Arancia G and Seiler N: Sensitization of human colon adenocarcinoma cells (LoVo) to reactive oxygen species by a lysosomotropic compound. Int J Oncol 29: 947-955, 2006.
76. Henle KJ, Moss AJ and Nagle WA: Mechanism of spermidine cytotoxicity at 37 degrees C and 43 degrees C in Chinese hamster ovary cells. Cancer Res 46: 175-182, 1986.
77. Bachrach U, Ash I, Abu-Elheiga L, Hershkovitz M and Loyter A: Fusion-mediated microinjection of active amine and diamine oxidases into cultured cells: effect on protein and DNA synthesis in chick embryo fibroblasts and in glioma cells. J Cell Physiol 131: 92-98, 1987.
78. Heby O and Persson L: Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem Sci 15: 153-158, 1990.
79. Calcabrini A, Arancia G, Marra M, Crateri P, Befani O, Martone A and Agostinelli E: Enzymatic oxidation products of spermine induce greater cytotoxic effects on human multidrugresistant colon carcinoma cells (LoVo) than on their wild type counterparts. Int J Cancer 99: 43-52, 2002.
80. Lindsay GS and Wallace HM: Changes in polyamine catabolism in HL-60 human promyelogenous leukaemic cells in response to etoposide-induced apoptosis. Biochem J 337: 83-87, 1999.
81. Toninello A, Pietrangeli P, De Marchi U, Salvi M and Mondovi B: Amine oxidases in apoptosis and cancer. Biochim Biophys Acta 1765: 1-13, 2006.
82. Arancia G, Calcabrini A, Marra M, Crateri P, Artico M, Martone A, Martelli F and Agostinelli E: Mitochondrial alterations induced by serum amine oxidase and spermine on human multidrug resistant tumor cells. Amino Acids 26: 273-282, 2004.
83. Kumar CS and Mohammad F: Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv Drug Deliv Rev 63: 789-808, 2011.
84. Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, Van der Zee J, Van Putten WL, Van Rhoon GC, Van Dijk JD, Gonzalez D, Liu FF, Goodman P and Sherar M: Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 35: 731-744, 1996.
85. Amendola R, Cervelli M, Fratini E, Sallustio DE, Tempera G, Ueshima T, Mariottini P and Agostinelli E: Reactive oxygen species spermine metabolites generated from amine oxidases and radiation represent a therapeutic gain in cancer treatments. Int J Oncol 43: 813-820, 2013.
86. Amendola R, Cervelli M, Tempera G, Fratini E, Varesio L, Mariottini P and Agostinelli E: Spermine metabolism and radiation-derived reactive oxygen species for future therapeutic implications in cancer: an additive or adaptive response. Amino Acids 46: 487-498, 2014.
87. Niemirowicz K, Markiewicz KH, Wilczewska AZ and Car H: Magnetic nanoparticles as new diagnostic tools in medicine. Adv Med Sci 57: 1-12, 2012.
88. Agostinelli E, Belli F, Dalla Vedova L, Marra M, Crateri P and Arancia G: Hyperthermia enhances cytotoxicity of amine oxidase and spermine on drug-resistant LoVo colon adenocarcinoma cells. Int J Oncol 28: 1543-1553, 2006.
89. Averill-Bates DA, Agostinelli E, Przybytkowski E and Mondovi B: Aldehyde dehydrogenase and cytotoxicity of purified bovine serum amine oxidase and spermine in Chinese hamster ovary cells. Biochem Cell Biol 72: 36-42, 1994.
90. Yoshikawa T, Kokura S, Tainaka K, Naito Y and Kondo M: A novel cancer therapy based on oxygen radicals. Cancer Res 55: 1617-1620, 1995.
91. Hahn GM: Hyperthermia and Cancer. Plenum Press, New York, 1982.
92. Gerner EW, Holmes DK, Stickney DG, Noterman JA and Fuller DJ: Enhancement of hyperthermia-induced cytotoxicity by polyamines. Cancer Res 40: 432-438, 1980.
93. Nagele A, Meier T and Issels RD: Thermosensitization, depletion of glutathione, and modulation of polyamine catabolism in CHO cells by the aminothiol WR-1065. Prog Pharm Clin Pharm 8: 176-180, 1990.
94. Kapp DS and Hahn GM: Thermosensitization by sulfhydryl compounds of exponentially growing Chinese hamster cells. Cancer Res 39: 4630-4635, 1979.
95. Averill-Bates DA, Agostinelli E, Przybytkowski E, Mateescu MA and Mondovì B: Cytotoxicity and kinetic analysis of purified bovine serum amine oxidase in the presence of spermine in Chinese hamster ovary cells. Arch Biochem Biophys 300: 75-79, 1993.
96. Agostinelli E, Przybytkowski E, Mondovì B and Averill-Bates DA: Heat enhancement of cytotoxicity induced by oxidation product of spermine in Chinese hamster ovary cells. Biochem Pharmacol 48: 1181-1186, 1994.
97. Demers N, Agostinelli E, Averill-Bates DA and Fortier G: Immobilization of native and polyethyleneglycol-treated ('PEGylated') bovine serum amine oxidase into a biocompatible hydrogel. Biotechnol Appl Biochem 33: 201-207, 2001.
98. Agostinelli E and Seiler N: Non-irradiation-derived reactive oxygen species (ROS) and cancer: therapeutic implications. Amino Acids 31: 341-355, 2006.
99. Agostinelli E, Riccio B, Mucigrosso J, Befani O and Mondovì B: On the handling of amine oxidase activity as a biochemical tool: perspectives. In: Perspectives in Polyamine Research. Perin A, Scalabrino G, Sessa A and Ferioli ME (eds). Wichtig Editor, Milan, pp17-19, 1988.
100. Dini L, Agostinelli E and Mondovì B: Cultured epatocytes bind and internalize bovine serum amine oxidase-gold complexes. Biochem Biophys Res Commun 179: 1169-1174, 1991.
101. Ansari SA and Husain Q: Potential applications of enzymes immobilized on/in nano materials: A review. Biotechnol Adv 30: 512-523, 2012.
102. Sasaki Y, Usuki N, Matsuo K and Kishimoto M: Development of NanoCAP technology for high-density recording. IEEE Trans Magn 41: 3241-3243, 2005.
103. Fouda MFR, El-Kholy MB, Moustafa SA, Hussien AI, Wahba MA and El-Shahat MF: Synthesis and characterization of nanosized Fe2O3 pigments. Int J Inorg Chem 2012: 1-9, 2012.
104. Magro M, Baratella D, Salviulo G, Polakova K, Zoppellaro G, Tucek J, Kaslik J, Zboril R and Vianello F: Core-shell hybrid nanomaterial based on prussian blue and surface active maghemite nanoparticles as stable electrocatalyst. Biosens Bioelectron 52 159-165, 2014.
105. Baratella D, Magro M, Sinigaglia G, Zboril R, Salviulo G and Vianello F: A glucose biosensor based on surface active maghemite nanoparticles. Biosens Bioelectron 45: 13-18, 2013.
106. Magro M, Baratella D, Pianca N, Toninello A, Grancara S, Zboril R and Vianello F: Electrochemical determination of hydrogen peroxide production by isolated mitochondria: a novel nanocomposite carbon-maghemite nanoparticle electrode. Sens Actuators B Chem 176: 315-322, 2013.
107. Magro M, Faralli A, Baratella D, Bertipaglia I, Giannetti S, Salviulo G, Zboril R and Vianello F: Avidin functionalized maghemite nanoparticles and their application for recombinant human biotinyl-SERCA purification. Langmuir 28: 15392-15401, 2012.
108. Tassa C, Shaw SY and Weissleder R: Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc Chem Res 44: 842-852, 2011.
109. Saito S, Tsugeno M, Koto D, Mori Y, Yoshioka Y, Nohara S and Murase K: Impact of surface coating and particle size on the uptake of small and ultrasmall superparamagnetic iron oxide nanoparticles by macrophages. Int J Nanomed 7: 5415-5421, 2012.
110. Wang J, Huang Y, David AE, Chertok B, Zhang L, Yu F and Yang VC: Magnetic nanoparticles for MRI of brain tumors. Curr Pharm Biotechnol 13: 2403-2416, 2012.
111. Skopalik J, Polakova K, Havrdova M, Justan I, Magro M, Milde D, Knopfova L, Smarda J, Polakova H, Gabrielova E, Vianello F, Michalek J and Zboril R: Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist - an initial in vitro study. Int J Nanomed 2014. http://dx.doi.org/10.2147/IJN.S66986.
112. Kanwar JR, Roy K and Kanwar RK: Chimeric aptamers in cancer cell-targeted drug delivery. Crit Rev Biochem Mol Biol 46: 459-477, 2011.
113. Kubinova S and Sykova E: Nanotechnologies in regenerative medicine. Minim Invasive Ther Allied Technol 19: 144-156, 2010.
114. Kiessling F, Huppert J, Zhang C, Jayapaul J, Zwick S, Woenne EC, Mueller MM, Zentgraf H, Eisenhut M, Addadi Y, Neeman M and Semmler W: RGD-labeled USPIO inhibits adhesion and endocytotic activity of alpha v beta3-integrinexpressing glioma cells and only accumulates in the vascular tumor compartment. Radiology 253: 462-469, 2009.
115. Dias AM, Hussain A, Marcos AS and Roque AC: A biotechnological perspective on the application of iron oxide magnetic colloids modified with polysaccharides. Biotechnol Adv 29: 142-155, 2011.
116. Hilger I and Kaiser WA: Iron oxide-based nanostructures for MRI and magnetic hyperthermia. Nanomedicine 7: 1443-1459, 2012.
117. Lin MM, Kim HH, Kim H, Dobson J and Kim do K: Surface activation and targeting strategies of superparamagnetic iron oxide nanoparticles in cancer-oriented diagnosis and therapy. Nanomedicine 5: 109-133, 2010.
118. Devi GR: siRNA-based approaches in cancer therapy. Cancer Gene Ther 13: 819-829, 2006.
119. Taratula O, Garbuzenko O, Savla R, Wang YA, He H and Minko T: Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes. Curr Drug Deliv 8: 59-69, 2011.
120. Jabir NR, Tabrez S, Ashraf GM, Shakil S, Damanhouri GA and Kamal MA: Nanotechnology-based approaches in anticancer research. Int J Nanomed 7: 4391-4408, 2012.
121. Magro M, Valle G, Russo U, Nodari L and Vianello F: Maghemite nanoparticles and method for preparing thereof. International Patent Application WO/2012/010200, 2012.
122. Sinigaglia G, Magro M, Miotto G, Cardillo S, Agostinelli E, Zboril R, Bidollari E and Vianello F: Catalytically active bovine serum amine oxidase bound to fluorescent and magnetically drivable nanoparticles. Int J Nanomed 7: 2249-2259, 2012.
123. Vijayanathan V, Agostinelli E, Thomas T and Thomas TJ: Innovative approaches to the use of polyamines for DNA nanoparticle preparation for gene therapy. Amino Acids 46: 499-509, 2014.
124. Boonstra J and Post JA: Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 337: 1-13, 2004.
125. Agostinelli E, Condello M, Molinari A, Tempera G, Viceconte N and Arancia G: Cytotoxicity of spermine oxidation products to multidrug resistant melanoma M14 ADR2 cells: Sensitization by the MDL 72527 lysosomotropic compound. Int J Oncol 35: 485-498, 2009.
126. Montanari E, Capece S, Di Meo C, Meringolo M, Coviello T, Agostinelli E and Matricardi P: Hyaluronic acid nanohydrogels as a useful tool for BSAO immobilization in the treatment of melanoma cancer cells. Macromol Biosci 13: 1185-1194, 2013.